PNPLA3 and metabolic dysfunction-associated steatotic liver disease: PNPLA3 GG allelic expression is known for conferring an augmented risk of development and severity of NALFD [7,53,54] and seems to modify the impact of different therapeutic strategies for NAFLD [55].